Form 4 for AGL agilon health, inc.
Accepted 2021-11-12 00:00:00 ET · period of report 2021-11-04 · accession 0001209191-21-064172 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2021-11-12 | 2021-11-04 | AGL | Sobotka Glenn | CAO | S - Sale+OE | $25.19 | -150.0K | 3,260 | -98% | -$3.78M |
| D | 2021-11-12 | 2021-11-04 | AGL | Sobotka Glenn | CAO | M - OptEx | $7.57 | +150.0K | 153.3K | +4,601% | +$1.14M |
| D | 2021-11-12 | 2021-11-04 | AGL | Sobotka Glenn | CAO | M - OptEx | $0.00 | -150.0K | 0 | -100% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2021-11-04 | S | D | 150,000 | $25.19 | 3,260 | D | — | — | (F1) Includes restricted stock units. |
| 2 | Common | Common Stock | 2021-11-04 | M | A | 150,000 | $7.57 | 153,260 | D | — | — | (F1) Includes restricted stock units. |
| 3 | Derivative | Options (Rights to Buy) | 2021-11-04 | M | D | 150,000 | $0.00 | 0 | D | $7.57 · — to 2029-02-02 | 150,000 Common Stock | (F2) These options were granted on February 9, 2019, and fully vested on September 14, 2021. |